Conway Charles

CIK 00017042561 companyNEW HAVEN, CT

SEC Profile

Transactions

Companies

Filings

CIK

0001704256

Recent Transactions

47 trades

Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Stock Options (Right to Buy)
2022-10-03−6,000→ 0 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Stock Options (Right to Buy)
2022-10-03−2,398→ 0 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Stock Options (Right to Buy)
2022-10-03−27,602→ 0 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Stock Options (Right to Buy)
2022-10-03−295→ 0 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Stock Options (Right to Buy)
2022-10-03−54,000→ 0 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Stock Options (Right to Buy)
2022-10-03−25,000→ 0 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Restricted Share Unit Award
2022-10-03−11,500→ 0 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Restricted Share Unit Award
2022-10-03−3,000→ 0 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2022-10-03$148.50/sh−22,362→ 0 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Restricted Share Unit Award
2022-10-03−7,500→ 0 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Stock Options (Right to Buy)
2022-10-03−775→ 0 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Stock Options (Right to Buy)
2022-10-03−25,225→ 0 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Stock Options (Right to Buy)
2022-10-03−3,084→ 0 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Stock Options (Right to Buy)
2022-10-03−61,916→ 0 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Stock Options (Right to Buy)
2022-10-03−41,432→ 0 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Stock Options (Right to Buy)
2022-10-03−5,000→ 0 total
Award
Biohaven Pharmaceutical Holding Co Ltd.
Employee Stock Option (right to buy)
2022-01-07+23,000→ 23,000 total
Award
Biohaven Pharmaceutical Holding Co Ltd.
Restricted Share Unit Award
2022-01-07+11,500→ 11,500 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Restricted Share Unit Award
2022-01-06−3,750→ 7,500 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2022-01-06+3,750→ 23,935 total
Tax Payment
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2022-01-06$123.86/sh−1,800→ 22,135 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2021-11-25+3,000→ 19,897 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Restricted Share Unit Award
2021-11-25−3,000→ 3,000 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2021-11-23$20.79/sh+885→ 16,897 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2021-11-23$37.54/sh+10,000→ 16,012 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Employee Stock Option (Right to Buy)
2021-11-23−10,000→ 0 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Employee Stock Option (Right to Buy)
2021-11-23−885→ 41,727 total
Tax Payment
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2021-01-06$83.38/sh−1,747→ 10,012 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Restricted Share Unit Award
2021-01-06−3,750→ 11,250 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2021-01-06+3,750→ 11,759 total
Award
Biohaven Pharmaceutical Holding Co Ltd.
Restricted Share Unit Award
2021-01-06+15,000→ 15,000 total
Award
Biohaven Pharmaceutical Holding Co Ltd.
Employee Stock Option (right to buy)
2021-01-06+30,000→ 30,000 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Restricted Share Unit Award
2020-11-25−3,000→ 6,000 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2020-11-25+3,000→ 8,639 total
Tax Payment
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2020-11-25$90.14/sh−1,361→ 7,278 total
Sale
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2020-06-17$72.15/sh−4,000→ 4,009 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2019-12-18+3,000→ 7,000 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Restricted Share Unit Award
2019-12-18−3,000→ 9,000 total
Tax Payment
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2019-12-18$52.13/sh−1,361→ 5,639 total
Award
Biohaven Pharmaceutical Holding Co Ltd.
Restricted Share Unit Award
2019-11-25+12,000→ 12,000 total
Award
Biohaven Pharmaceutical Holding Co Ltd.
Employee Stock Option (Right to Buy)
2019-11-25+25,000→ 25,000 total
Award
Biohaven Pharmaceutical Holding Co Ltd.
Stock Option (Right to Buy)
2019-06-27+6,000→ 6,000 total
Award
Biohaven Pharmaceutical Holding Co Ltd.
Stock Option (Right to Buy)
2018-11-20+65,000→ 65,000 total
Award
Biohaven Pharmaceutical Holding Co Ltd.
Employee Stock Option (Right to Buy)
2017-12-07+42,612→ 42,612 total
Award
Biohaven Pharmaceutical Holding Co Ltd.
Employee Stock Option (Right to Buy)
2017-12-07+32,612→ 32,612 total
Award
Biohaven Pharmaceutical Holding Co Ltd.
Employee Stock Option (right to buy)
2017-09-05+10,000→ 10,000 total
Purchase
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2017-05-09$17.00/sh+4,000→ 4,000 total

Companies

Biohaven Pharmaceutical Holding Co Ltd.
Chief Scientific Officer

Recent Filings

Address

C/O BIOHAVEN PHARMACEUTICALS, INC. 234 CHURCH STREET

NEW HAVEN, CT, 06510

View on SEC.gov